Latest News
The following news articles were published in 2021.
PhD Student secures RSE Saltire Early Career Fellowship
Esme Bullock, one of our PhD Students, has been awarded a fellowship to advance her breast cancer research project: October 2021
Higher rates of mutation alone are not sufficient to cause ageing
A study has found that human cells and tissues can accumulate many more mutations than are normally present, without the body showing the features associated with ageing: October 2021
Licensing of a SRC/YES1 inhibitor with novel mode of action
Nuvectis Pharma, a biopharmaceutical company focused on the development of innovative precision medicines, has licensed exclusive worldwide rights to develop and commercialize a novel SRC/YES1 inhibitor discovered at the CRUK Edinburgh Centre: September 2021
Clinical trial identifies effective adjuvant therapy for patients with kidney cancer
KEYNOTE-564 clinical study, with important contributions from the UK that were led from Edinburgh, shows that adjuvant immunotherapy following surgery improves disease-free survival in patients with clear cell renal cell carcinoma: August 2021
The impact of the Covid-19 pandemic on breast cancer early detection and screening
Dr Jonine Figueroa and international colleagues report on the impact of the Covid-19 on breast cancer early detection and screening providing important information to help mitigate the impact of the pandemic on early diagnosis and treatment.
Opportunities for stratification in endometrioid ovarian carcinoma
Edinburgh researchers used unique dataset that combines hormone receptor expression patterns with matched genomic characterisation to identify opportunities for patient stratification in endometrioid ovarian carcinoma: June 2021
Optimizing treatment for the older and frailer cancer patients
Study with important contributions from Edinburgh investigators finds that less chemotherapy is noninferior to more in frail and elderly patients with advanced gastroesophageal cancer: May 2021
RAC1B is an important mediator of colorectal tumourigenesis
Cancer Research UK Edinburgh Centre scientists identify RAC1B as an important mediator of colorectal tumourigenesis and a potential target for enhancing the efficacy of EGFR inhibitor treatment: April 2021
New insights into how severe brain cancer evades immune attack
Cancer Research UK Edinburgh Centre researchers uncover mechanisms underlying immune evasion in Glioblastoma multiforme (GBM): April 2021
IGMM renamed the Institute of Genetics and Cancer
From 1 April the Institute of Genetics and Molecular Medicine (IGMM) will go by a new name, the Institute of Genetics and Cancer (IGC): April 2021
RSE Fellowship for Liz Patton
Prof Liz Patton of the MRC Human Genetic Unit and CRUK Edinburgh Centre have been selected as Fellow of the Royal Society of Edinburgh: March 2021
Focal Adhesion Kinase controls transcription via chromatin accessibility
A study led by CRUK Edinburgh Centre scientists provides the first demonstration that Focal Adhesion Kinase controls transcription via chromatin accessibility: January 2021
AI - empowered personalized cancer medicine
Edinburgh researchers in a pan-European consortium to develop user friendly Artificial Intelligence (AI) tools for cancer clinicians: November 2020
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
A study led by Cancer Research UK Edinburgh Centre researchers provides improved molecular taxonomy of endometrioid ovarian carcinoma and identifies candidate targets for molecular therapeutics: October 2020
Sarah Taylor wins Max Perutz Science Writing Award
Sarah, who is on a Doctoral Training Programme with the Cancer Research UK Edinburgh Centre at IGMM, told us how it feels to see her winning essay published in The Observer: October 2020.